ALBBY (Alibaba Health Information Technology) Cash Flow for Dividends: $0 Mil (TTM As of Mar. 2026)


ALBBY Alibaba Health Information Technology Ltd ALBBY
73 GF Score
Price $7.92
GF Value $13.36
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Alibaba Health Information Technology Cash Flow for Dividends?

Alibaba Health Information Technology ALBBY +1.12% 73 Cash Flow for Dividends is $0 Mil as of Mar. 2026. GuruFocus rates ALBBY with a GF Score™ of 73/100 and a GF Value™ of $13.36 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Alibaba Health Information Technology's cash flow for dividends for the six months ended in Mar. 2026 was $0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Alibaba Health Information Technology Cash Flow for Dividends Related Terms

Alibaba Health Information Technology Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Alibaba Health Information Technology's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alibaba Health Information Technology Cash Flow for Dividends Chart

Alibaba Health Information Technology Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Alibaba Health Information Technology Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ALBBY
73GF Score
Alibaba Health Information Technology Ltd ALBBY
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alibaba Health Information Technology Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of $0 Mil mean?
Alibaba Health Information Technology (ALBBY) has a Cash Flow for Dividends of $0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Alibaba Health Information Technology and its competitors.
Is Alibaba Health Information Technology's Cash Flow for Dividends too high?
Alibaba Health Information Technology's current Cash Flow for Dividends is $0 Mil. Overall, Alibaba Health Information Technology has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's Cash Flow for Dividends compare to competitors?
Alibaba Health Information Technology's Cash Flow for Dividends of $0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Healthcare Providers & Services company?
A good Cash Flow for Dividends depends on the Healthcare Providers & Services industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Alibaba Health Information Technology and its competitors. Alibaba Health Information Technology's current Cash Flow for Dividends is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBBY) is currently considered Significantly Undervalued. The stock's GF Value™ is $13.36, compared to a current price of $7.92 — trading 40.7% below its estimated fair value. The current Cash Flow for Dividends is $0 Mil. Alibaba Health Information Technology's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBBY), the current Cash Flow for Dividends is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alibaba Health Information Technology (ALBBY) Overvalued in 2026?

Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued. The current stock price of $7.92 is trading 40.7% below its estimated GF Value™ of $13.36. GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.

Key valuation signals for ALBBY:

  • Cash Flow for Dividends: $0 Mil
  • GF Value™: $13.36 vs. price of $7.92 (40.7% below fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the ALBBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alibaba Health Information Technology Business Description

Address Wangjing East Park, 30th Floor, Greenland Center, Building 9, Zone 4, Chaoyang District, Beijing, CHN
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
73GF Score

Get the complete analysis for ALBBY

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.92
Price
$13.36
GF Value